Introduction In many emerging markets — especially India — traditional pharmaceutical marketing relies heavily on in-person medical representative (MR) visits to doctors. While this model dominated for decades, substantial evidence now shows it often fails to deliver efficient, consistent doctor engagement — especially in remote, non-metro regions. This results in major portions of field marketing…